Showing 5501-5510 of 5909 results for "".
- Draper James and VSP Eyes of Hope Commit Nearly $4 Million to Fund Eye Care and Eyewear in Support of Young Womenhttps://modernod.com/news/draper-james-and-vsp-eyes-of-hope-commit-nearly-4-million-to-fund-eye-care-and-eyewear-in-support-of-young-women/2476637/More women than men are at risk for vision loss from eye diseases like glaucoma and macular degeneration. To help ensure more women have access to critical eye care, Draper James, the Southern-inspired lifestyle brand founded by Reese Witherspoon, announced a partne
- More Elderly Americans Dying From Fallshttps://modernod.com/news/more-elderly-americans-dying-from-falls/2476634/Death rates from falls are rising among elderly Americans and climbing fastest among seniors in their 90s, a US study suggests. Among all adults 75 and older, mortality from falls climbed 5.1% from 2000 to 2016, researchers report in JAMA. Death rates from falls rose the most—6.4%—among
- Pioneering Ophthalmologist Patricia Bath, MD, Dies at 76https://modernod.com/news/pioneering-ophthalmologist-patricia-bath-md-dies-at-76/2476632/Patricia E. Bath, MD, an ophthalmologist who took a special interest in combating preventable blindness in underserved populations and became the first black female doctor to patent a medical invention, a laser device for treating cataracts, died at the age of 76, acc
- Re-Vana Therapeutics Names International Experts to Inaugural Scientific Advisory Boardhttps://modernod.com/news/re-vana-therapeutics-names-international-experts-to-inaugural-scientific-advisory-board/2476628/Re-Vana Therapeutics announced the formation of its new Scientific Advisory Board (SAB). The newly appointed SAB will strategically advise and support Re-Vana as it develops innovative therapies for a broad range of ophthalmic indications, including wet age-related macular degeneration (AMD), dia
- Verseon Showcases Oral Candidates for Next-Generation Diabetic Eye Disease Drugshttps://modernod.com/news/verseon-showcases-oral-candidates-for-next-generation-diabetic-eye-disease-drugs/2476626/Verseon presented a new class of oral candidate drugs which could change the treatment and prevention of diabetic macular edema (DME). “Our oral development candidate, a novel inhibitor of plasma kallikrein, has the potential to redefine how DME is treated,” Dr. Anirban Datta, Verse
- Precision Medicine to Prevent Glaucoma-Related Blindnesshttps://modernod.com/news/precision-medicine-to-prevent-glaucoma-related-blindness/2476617/Approximately 10% of patients become blind despite using evidence-based guidelines developed from clinical trials and epidemiology studies. Our purpose is to review opportunities to decrease glaucoma-related blindness using the emerging principles of precision medicine.
- Study: 3D Printed Artificial Corneas Similar to Human Oneshttps://modernod.com/news/study-3d-printed-artificial-corneas-similar-to-human-ones/2476615/When a person has a severely damaged cornea, a corneal transplant is required. However, there are 2,000 patients waiting for the cornea donation in the country as of 2018, and they wait for 6 or more years on average for the donation. For this reason, many scientists have put their efforts in dev
- Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitishttps://modernod.com/news/central-retinal-vein-occlusion-rarely-complicates-ulcerative-colitis/2476609/Central retinal vein occlusion (CRVO) can rarely complicate the course of inflammatory bowel disease (IBD), according to a case series, as reported by Reuters. As many as 11.8% of patients with IBD can develop ophthalmological compl
- RAZ Mobility Launches Accessible Mobile Phone for Individuals with Impaired Visionhttps://modernod.com/news/raz-mobility-launches-accessible-mobile-phone-for-individuals-with-impaired-vision/2476607/RAZ Mobility has announced the launch of the Lucia, a mobile phone specifically designed to address the unique needs of people who are blind, low vision, or hard of hearing. Someone who is completely blind can use Lucia just as fully and effectively as someone who is sighted. According to
- Biophytis Files Registration Statement for Proposed Initial Public Offering in the United Stateshttps://modernod.com/news/biophytis-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/2476604/Biophytis announced that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) in relation to a proposed initial public offering of American Depositary Shares representing ordinary shares of Biophytis. Biophytis has applied to list its shares